Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

External Quality Assessment Scheme for HIV-1 Drug-Resistance Genotyping in Thailand.

AIDS research and human retroviruses - 1 Dec 2018

Saeng-Aroon Siriphan, Saipradit Nonglak, Loket Ruangchai, Klamkhai Nattapong, Boonmuang Ratrawee, Kaewprommal Pavita, Prommajan Korrakot, Takeda Naokazu, Sungkanuparph Somnuek, Shioda Tatsuo, Sangkitporn Somchai, Motomura Kazushi

Abstract excerpt

The efficacy of antiretroviral (ARV) therapy can be compromised by the emergence and transmission of HIV-1 drug-resistant strains. HIV-1 drug-resistance (DR) genotypic testing thus plays an important role in the selection of optimal treatment regimens for HIV-infected individuals. Given the complexities of the testing procedures and the variety of approaches used, there is considerable potential for results to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Thailand

Source

Identifiers

PMID: 30215266
DOI: 10.1089/AID.2017.0299

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

External Quality Assessment Scheme for HIV-1 Drug-Resistance Genotyping in Thailand.PMID 30215266Read ↗

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.Semantic proximity Read ↗

TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesSemantic proximity Read ↗

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Semantic proximity Read ↗

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.Semantic proximity Read ↗

Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites.Semantic proximity Read ↗

HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency ProgrammeSemantic proximity Read ↗

Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.Semantic proximity Read ↗

[Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].Semantic proximity Read ↗

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.Semantic proximity Read ↗

A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples.Semantic proximity Read ↗

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.Semantic proximity Read ↗

Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.